In urology clinical practice, benign prostatic hyperplasia is a common chronic disease among middle-aged and elderly men. Symptoms such as frequent urination, urgent urination, and difficulty in urination seriously affect the quality of life of patients. For patients with severe hyperplasia and ineffective drug treatment, minimally invasive surgical treatment is the core solution.

For a long time, TURP (Transurethral Resection of the Prostate) has been the standard surgical procedure for prostate surgeries and has been widely used in clinical practice. However, with the continuous advancement of minimally invasive techniques, HoLEP (Transurethral Holmium Laser Prostate Enucleation) has broken through the limitations of traditional surgeries and gradually become the preferred treatment option for minimally invasive urological surgeries.


【The shortcomings of the traditional TURP surgery】
The TURP surgical technique is mature and widely adopted, but it has unavoidable clinical limitations that significantly restrict its applicable scenarios:
The first is the strict limitation on gland size. The clinical consensus clearly states that TURP is only applicable to small to medium-sized prostates. When dealing with large-volume and severely hypertrophied prostate tissues, complete removal cannot be achieved, and there is a high risk of tissue residue, postoperative recurrence, and a relatively high rate of requiring a second operation.

The second issue is the higher risk of bleeding. The traditional electroresection method has limited effectiveness in closing blood vessels, and during the operation and after the surgery, there is a tendency for the wound to bleed. This not only increases the probability of blood transfusion during the operation but may also cause postoperative hematuria, infection and other complications, prolonging the hospital stay and recovery period. Additionally, TURP carries the risk of electrocuting syndrome, which requires a higher tolerance level from the patient's body.


【The core advantages of HOLEP】
Compared with TURP (Transurethral Resection of the Prostate), HoLEP (Ho-Laser Enucleation of the Prostate) has achieved a technological breakthrough, effectively addressing the core problems of traditional surgery, being applicable to a wider range of clinical cases, and significantly enhancing its safety and applicability.

1.Reduce risks and enhance the safety of minimally invasive procedures
HoLEP takes advantage of the precise tissue cutting and hemostasis characteristics of holmium laser to achieve simultaneous cutting and hemostasis. The laser energy can precisely seal the tiny blood vessels at the wound site, significantly reducing the amount of intraoperative bleeding. The decrease in hemoglobin levels is much lower than that of TURP surgery, and the probability of intraoperative blood transfusion is significantly reduced.

At the same time, the surgical trauma is extremely minimal, and the incidence of postoperative complications such as hematuria, edema, and infection is even lower. Patients recover faster after the surgery, and the duration of indwelling urinary catheter and hospital stay are significantly shortened. It is particularly suitable for high-risk patients who are elderly, have weak constitutions, and have underlying diseases. The clinical safety advantage is remarkable.

2.Not limited by the size of the prostate
This is the most crucial differentiating advantage of HoLEP compared to TURP. Unlike TURP which imposes strict limitations on the volume of the prostate, HoLEP has no size threshold for the glandular tissue. Whether it is a small volume with mild hyperplasia or an extremely large volume with severe prostate hyperplasia, it can be applicable.

The surgery can precisely remove the hyperplastic tissues along the surgical capsule of the prostate, achieving a more thorough removal. This minimizes tissue residue and significantly reduces the probabilities of postoperative recurrence and secondary interventions. The long-term treatment effect is more stable, completely filling the technical gap of traditional surgeries in the treatment of large-volume prostates.


【The simulation model helps to standardize practical training】
In response to the pain points of HoLEP clinical training, MAXSEAS relies on 3D printing precision replication technology to create a prostate hyperplasia minimally invasive surgery simulation training model. This model highly replicates the real anatomical structure, tissue elasticity and vascular distribution of the human prostate, and precisely simulates the shapes of different volume prostate hyperplasia lesions.

The model is perfectly compatible with mainstream minimally invasive surgical procedures such as HoLEP and TURP. It supports full-process simulation exercises including laser excision, tissue cutting, hemostasis operations, and wound treatment, allowing for the most accurate reproduction of the real surgical feel and operational scenarios.
· Break through the limitations of practical training: Without relying on clinical cases, standardized practical training can be repeatedly conducted, helping physicians master the excision technique for prostate of different sizes proficiently;
· Reduce training risks: Avoid clinical practical operation risks, assist physicians in predicting surgical difficulties and avoiding operational mistakes, and enhance the ability to stop bleeding during surgery and perform precise removal;
· Suitable for teaching scenarios: Applicable to hospital residency training, university teaching, and physician skill advancement training. It can quickly lay a solid foundation for minimally invasive surgeries and help promote the standardized and popularization of HoLEP technology.


【Summary】
From limited adaptation to comprehensive coverage, from high-risk bleeding to minimally invasive safety, HoLEP has gradually gained popularity in clinical practice thanks to its advantages of no size restrictions, low bleeding, and high cure rate.

High-quality minimally invasive techniques cannot be achieved without a standardized practical training system. MAXSEAS has broken down the barrier between theory and clinical practice through high-precision simulation models, helping urologists rapidly improve the core technology of HoLEP and providing patients with safer, more efficient and more precise minimally invasive treatment services.